Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Russell Middaugh

Showing results (171-180 of 271) with videos related to

Pageof 28
Sort By:
Journal of Pharmaceutical Sciences|October 3, 2009
Use of a folding model and in situ spectroscopic techniques for rational formulation development and stability testing of monoclonal antibody therapeuticsGauri Rao, Vandana Iyer, Matthew P Kosloski, et al.
Journal of Pharmaceutical Sciences|October 11, 2014
Calculating the mass of subvisible protein particles with improved accuracy using microflow imaging dataCavan Kalonia, Ozan S Kumru, Indira Prajapati, et al.
Journal of Pharmaceutical Sciences|January 24, 2014
Structural characterization of IgG1 mAb aggregates and particles generated under various stress conditionsSrivalli N Telikepalli, Ozan S Kumru, Cavan Kalonia, et al.
Mabs|December 20, 2014
Correlations between changes in conformational dynamics and physical stability in a mutant IgG1 mAb engineered for extended serum half-lifeRanajoy Majumdar, Reza Esfandiary, Steven M Bishop, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 14, 2016
Challenges and opportunities of using liquid chromatography and mass spectrometry methods to develop complex vaccine antigens as pharmaceutical dosage formsJohn M Hickey, Neha Sahni, Ronald T Toth, et al.
Vaccine|May 29, 2017
Development of a candidate stabilizing formulation for bulk storage of a double mutant heat labile toxin (dmLT) protein based adjuvantVishal M Toprani, Neha Sahni, John M Hickey, et al.
Journal of Pharmaceutical Sciences|September 17, 2010
Formulation and immunogenicity studies of type III secretion system needle antigens as vaccine candidatesBrooke S Barrett, Aaron P Markham, Reza Esfandiary, et al.
Protein Science : a Publication of the Protein Society|December 21, 2016
Effect of acrylodan conjugation and forced oxidation on the structural integrity, conformational stability, and binding activity of a glucose binding protein SM4 used in a prototype continuous glucose monitorJohn M Hickey, Neha Sahni, Rajoshi Chaudhuri, et al.
Journal of Pharmaceutical Sciences|September 17, 2010
Formulation and immunogenicity of a potential multivalent type III secretion system-based protein vaccineAaron P Markham, Brooke S Barrett, Reza Esfandiary, et al.
Journal of Pharmaceutical Sciences|August 27, 2010
Identifying stabilizers of plasmid DNA for pharmaceutical useYuhong Zeng, Joshua D Ramsey, Robert King, et al.
Pageof 28

Showing results (171-180 of 271) with videos related to

Sort By:
Pageof 28
Journal of Pharmaceutical Sciences|October 3, 2009
Use of a folding model and in situ spectroscopic techniques for rational formulation development and stability testing of monoclonal antibody therapeuticsGauri Rao, Vandana Iyer, Matthew P Kosloski, et al.
Journal of Pharmaceutical Sciences|October 11, 2014
Calculating the mass of subvisible protein particles with improved accuracy using microflow imaging dataCavan Kalonia, Ozan S Kumru, Indira Prajapati, et al.
Journal of Pharmaceutical Sciences|January 24, 2014
Structural characterization of IgG1 mAb aggregates and particles generated under various stress conditionsSrivalli N Telikepalli, Ozan S Kumru, Cavan Kalonia, et al.
Mabs|December 20, 2014
Correlations between changes in conformational dynamics and physical stability in a mutant IgG1 mAb engineered for extended serum half-lifeRanajoy Majumdar, Reza Esfandiary, Steven M Bishop, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 14, 2016
Challenges and opportunities of using liquid chromatography and mass spectrometry methods to develop complex vaccine antigens as pharmaceutical dosage formsJohn M Hickey, Neha Sahni, Ronald T Toth, et al.
Vaccine|May 29, 2017
Development of a candidate stabilizing formulation for bulk storage of a double mutant heat labile toxin (dmLT) protein based adjuvantVishal M Toprani, Neha Sahni, John M Hickey, et al.
Journal of Pharmaceutical Sciences|September 17, 2010
Formulation and immunogenicity studies of type III secretion system needle antigens as vaccine candidatesBrooke S Barrett, Aaron P Markham, Reza Esfandiary, et al.
Protein Science : a Publication of the Protein Society|December 21, 2016
Effect of acrylodan conjugation and forced oxidation on the structural integrity, conformational stability, and binding activity of a glucose binding protein SM4 used in a prototype continuous glucose monitorJohn M Hickey, Neha Sahni, Rajoshi Chaudhuri, et al.
Journal of Pharmaceutical Sciences|September 17, 2010
Formulation and immunogenicity of a potential multivalent type III secretion system-based protein vaccineAaron P Markham, Brooke S Barrett, Reza Esfandiary, et al.
Journal of Pharmaceutical Sciences|August 27, 2010
Identifying stabilizers of plasmid DNA for pharmaceutical useYuhong Zeng, Joshua D Ramsey, Robert King, et al.
Pageof 28